OBJECTIVE: This research study attempted to develop spray-dried solid dispersion, to enhance the solubility of repaglinide, an antidiabetic drug. SIGNIFICANCE: Aqueous solubility plays a major role in drug delivery because any chemical entity has to be in a dissolved state at the site of absorption, in order to get absorbed. Solid dispersion (SD) is one of the widely used techniques to enhance solubility and hence dissolution rate of poorly soluble drugs. METHODS: Repagnilide, in hypromellose acetate succinate (HPMCAS) solution, was dried by spray drying to obtain spray-dried solid dispersion (SDSD). Plackett-Burman and Box-Behnken designs were used for screening formulation as well as process parameters, and optimization respectively. DSC, XRD, SEM were carried out to confirm the preparation of solid dispersion. SDSD was evaluated for in vitro dissolution, flow properties, Percentage yield and in vivo oral glucose tolerance test. RESULT: Spray dried solid dispersion comprising (w/w) drug:polymer ratio of 1:3.82, 2.56% of aerosil and inlet temperature of 90 °C, corresponded to the best formulation obtained in this work. It showed t 85% of less than 15 min and a significant reduction in blood glucose level in rats as compared to pure drug and marketed formulation. CONCLUSION: Thus, it can be concluded that spray-dried solid dispersion prepared using HPMCAS is a useful technique for solubility and dissolution enhancement of repaglinide.
OBJECTIVE: This research study attempted to develop spray-dried solid dispersion, to enhance the solubility of repaglinide, an antidiabetic drug. SIGNIFICANCE: Aqueous solubility plays a major role in drug delivery because any chemical entity has to be in a dissolved state at the site of absorption, in order to get absorbed. Solid dispersion (SD) is one of the widely used techniques to enhance solubility and hence dissolution rate of poorly soluble drugs. METHODS:Repagnilide, in hypromellose acetate succinate (HPMCAS) solution, was dried by spray drying to obtain spray-dried solid dispersion (SDSD). Plackett-Burman and Box-Behnken designs were used for screening formulation as well as process parameters, and optimization respectively. DSC, XRD, SEM were carried out to confirm the preparation of solid dispersion. SDSD was evaluated for in vitro dissolution, flow properties, Percentage yield and in vivo oral glucose tolerance test. RESULT: Spray dried solid dispersion comprising (w/w) drug:polymer ratio of 1:3.82, 2.56% of aerosil and inlet temperature of 90 °C, corresponded to the best formulation obtained in this work. It showed t 85% of less than 15 min and a significant reduction in blood glucose level in rats as compared to pure drug and marketed formulation. CONCLUSION: Thus, it can be concluded that spray-dried solid dispersion prepared using HPMCAS is a useful technique for solubility and dissolution enhancement of repaglinide.